Remote limb ischemic postconditioning protects mouse brain against cerebral ischemia/reperfusion injury via upregulating expression of Nrf2, HO-1 and NQO-1 in mice

International Journal of Neuroscience

Volumn 126, Issue 6, 2016, Pages 552-559

  Li, Pan ^a   Su, Likai ^a   Li, Xiaofang ^a   Di, Weiying ^a   Zhang, Xiangjian ^b,c,d   Zhang, Cong ^b   He, Tingting ^b   Zhu, Xingyuan ^b   Zhang, Ye ^b   Li, Yaoru ^b  

^a HEBEI UNIVERSITY   (China)

^b HEBEI MEDICAL UNIVERSITY   (China)

^c Hebei Collaborative Innovation Center for Cardio Cerebrovascular Disease   (China)

^d Hebei Key Laboratory for Neurology   (China)

Author keywords

antioxidative stress; cerebral ischemia; ischemia reperfusion injury; neuroprotection; remote ischemic postconditioning

Indexed keywords

HEME OXYGENASE 1; MALONALDEHYDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (QUINONE); SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR NRF2;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT RESPONSIVE ELEMENT; ARTICLE; BRAIN EDEMA; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; FEMORAL ARTERY; ISCHEMIC POSTCONDITIONING; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; REPERFUSION INJURY; UPREGULATION;

EID: 84941662108     PISSN: 00207454     EISSN: 15635279     Source Type: Journal    
DOI: 10.3109/00207454.2015.1042973     Document Type: Article

References (34)

1. Venna VR, Li J, Benashski SE, et al. Preconditioning induces sustained neuroprotection by downregulation of adenosine 5′-monophosphate-activated protein kinase. Neuroscience 2012; 201: 280-7.
2. Liu J, Xu Q, Wang H, et al. Neuroprotection of ischemic postconditioning by downregulating the postsynaptic signaling mediated by kainate receptors. Stroke 2013; 44 (7): 2031-5.
3. Tu XK, Yang WZ, Chen JP, et al. Repetitive ischemic preconditioning attenuates inflammatory reaction and brain damage after focal cerebral ischemia in rats: involvement of PI3K/Akt and ERK1/2 signaling pathway. J Mol Neurosci 2014; 55 (4): 912-22.
4. Zhao H, Wang R, Tao Z, et al. Ischemic postconditioning relieves cerebral ischemia and reperfusion injury through activating T-LAK cell-originated protein kinase/protein kinase B pathway in rats. Stroke 2014; 45 (8): 2417-24.
5. Loukogeorgakis SP, Panagiotidou AT, Broadhead MW, et al. Remote ischemic preconditioning provides early and late protection against endothelial ischemiareperfusion injury in humans: role of the autonomic nervous system. J Am Coll Cardiol 2005; 46 (3): 450-6.
6. Ren C, Gao M, Dornbos D III, et al. Remote ischemic post-conditioning reduced brain damage in experimental ischemia/reperfusion injury. Neurol Res 2011; 33: 514-9.
7. Hess DC, Hoda MN, Bhatia K. Remote limb perconditioning [corrected] and postconditioning: will it translate into a promising treatment for acute stroke? Stroke 2013; 44 (4): 1191-7.
8. Lo EH, Dalkara T, Moskowitz MA. Mechanisms, challenges and opportunities in stroke. Nat Rev Neurosci 2003; 4: 399-415.
9. Sutherland BA, Minnerup J, Balami JS, et al. Neuroprotection for ischemic stroke: translation from the bench to the bedside. Int J Stroke 2012; 7: 407-18.
10. Gursoy-Ozdemir Y, Can A, Dalkara T. Reperfusion-induced oxidative/nitrative injury to neurovascular unit after focal cerebral ischemia. Stroke 2004; 35: 1449-53.
11. Rodrigo R, Fernández-Gajardo R, Gutiérrez R, et al. Oxidative stress and pathophysiology of ischemic stroke: novel therapeutic opportunities. CNS Neurol Disord Drug Targets 2013; 12: 698-714.
12. Manzanero S, Santro T, Arumugam TV. Neuronal oxidative stress in acute ischemic stroke: sources and contribution to cell injury. Neurochem Int 2013; 62 (5): 712-8.
13. 2+ overload. Am J Physiol Heart Circ Physiol 2005; 288 (4): H1900-8.
14. Li ZY, Liu B, Yu J, et al. Ischaemic postconditioning rescues brain injury caused by focal ischaemia/reperfusion via attenuation of protein oxidization. J Int Med Res 2012; 40 (3): 954-66.
15. Lee JM, Li J, Johnson DA, et al. Nrf2, a multi-organ protector? FASEB J 2005; 19: 1061-6.
16. Gururaj Joshi, Jeffrey A. Johnson. The Nrf2-ARE pathway: a valuable therapeutic target for the treatment of neurodegenerative diseases. Recent Pat CNS Drug Discov 2012; 7 (3): 218-29.
17. Innamorato NG, Lastres-Becker I, Cuadrado A. Role of microglial redox balance in modulation of neuroinflammation. Curr Opin Neurol 2009; 22: 308-14.
18. Innamorato NG, Rojo AI, García-Yagüe AJ, et al. The transcription factor Nrf2 is a therapeutic target against brain inflammation. J Immunol 2008; 181: 680-9.
19. Zhou C, Li H, Yao Y, et al. Delayed remote ischemic preconditioning produces an additive cardioprotection to sevoflurane postconditioning through an enhanced heme oxygenase 1 level partly via nuclear factor erythroid 2-related factor 2 nuclear translocation. J Cardiovasc Pharmacol Ther 2014; 19 (6): 558-66.
20. Wang L, Li Z, Zhang X, et al. Protective effect of shikonin in experimental ischemic stroke: attenuated TLR4, p-p38MAPK, NF-kB, TNF-αand MMP-9 expression, up-regulated claudin-5 expression, ameliorated BBB permeability. Neurochem Res 2014; 39: 97-106.
21. Hill JK, Gunion-Rinker L, Kulhanek D, et al. Temporal modulation of cytokine expression following focal cerebralischemia in mice. Brain Res 1999; 820: 45-54.
22. Hatashita S, Hoff JT, Salamat SM. Ischemic brain edema and the osmotic gradient between blood and brain. J Cereb Blood Flow Metab 1988; 8: 552-9.
23. Bederson JB, Pitts LH, Germano SM, et al. Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. Stroke 1986; 17 (6): 1304-8.
24. Chan PK. Reactive oxygen radicals in signaling and damage in the ischemic brain. J Cereb Blood Flow Metab 2001; 21 (1): 2-14.
25. Schettler V, Methe H, Staschinsky D, et al. Review: the oxidant/antioxidant balance during regular low density lipoprotein apheresis. Ther Apher 1999; 3: 219-26.
26. Joshi G, Johnson JA. The Nrf2-ARE pathway: a valuable therapeutic target for the treatment of neurodegenerative diseases. Recent Pat CNS Drug Discov 2012; 7 (3): 218-29.
27. Alfieri A, Srivastava S, Siow RC, et al. Sulforaphane preconditioning of the Nrf2/HO-1 defense pathway protects the cerebral vasculature against blood-brain barrier disruption and neurological deficits in stroke. Free Radic Biol Med 2013; 65: 1012-22.
28. Wu J, Li Q, Wang X, et al. Neuroprotection by curcumin in ischemic brain injury involves the Akt/Nrf2 pathway. PLoS One 2013; 8 (3): e59843.
29. Deshane J, Wright M, Agarwal, A. Heme oxygenase-1 expression in disease states. Acta Biochim Pol 2005; 52: 273-84.
30. Dore S, Snyder SH. Neuroprotective action of bilirubin against oxidative stress in primary hippocampal cultures. Ann N Y Acad Sci. 1999; 890: 167-72.
31. Satoh T, Kosaka K, Itoh K, et al. Carnosic acid, a catechol-type electrophilic compound, protects neurons both in vitro and in vivo through activation of the Keap1/Nrf2 pathway via S-alkylation of targeted cysteines on Keap1. Neurosci Lett 2008; 434: 260-5.
32. Lind C, Cadenas E, Hochstein P, et al. DT-diaphorase: purification, properties, and function. Methods Enzymol 1990; 186: 287-301.
33. Li Y, Jaiswal AK. Human antioxidant-response-element-mediated regulation of type 1 NAD(P)H: quinone oxidoreductase gene expression. Effect of sulfhydryl modifying agents. Eur J Biochem 1994; 226: 31-9.
34. Siegel D, Ross D. Immunodetection of NAD(P)H:quinone oxidoreductase 1 (NQO1) in human tissues. Free Radic Biol Med 2000; 29: 246-53.